174 related articles for article (PubMed ID: 38130989)
1. Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis.
Lin G; Liu H; Lin J; Liu X; Xu L
Front Oncol; 2023; 13():1286610. PubMed ID: 38130989
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of long noncoding RNA TTN-AS1 in various malignancies.
Lin G; Liu X; Cong C; Xu L
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1876. PubMed ID: 37528740
[TBL] [Abstract][Full Text] [Related]
3. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
4. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
Shu Q; Liu X; Yang J; Mou T; Xie F
Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
[TBL] [Abstract][Full Text] [Related]
5. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
Li C; Wu R; Xing Y
Cell Cycle; 2020 Mar; 19(5):601-609. PubMed ID: 32079456
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers.
Huang Z; Zhang M; Li J; Lou C
Biomed Pharmacother; 2023 Jul; 163():114756. PubMed ID: 37105079
[TBL] [Abstract][Full Text] [Related]
7. Prognostic effect of lncRNA BBOX1-AS1 in malignancies: a meta-analysis.
Lin G; Wang Y; Deng L; Ye T
Front Genet; 2023; 14():1234040. PubMed ID: 37636267
[No Abstract] [Full Text] [Related]
8. Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients: A Meta-analysis.
Zhou X; Fan YH; Wang Y; Wang F; Liu Y
Medicine (Baltimore); 2019 Apr; 98(17):e15251. PubMed ID: 31027073
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA MAFG-AS1 as a Potential Biomarker for Hepatocellular Carcinoma: Linkage with Tumor Features, Markers, Liver Functions, and Survival Profile.
Tian Y; Wang J; Tian G; Li B; Chen M; Sun X
Front Surg; 2022; 9():848831. PubMed ID: 36034393
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway.
Di S; Bai R; Lu D; Chen C; Ma T; Zou Z; Zhang Z
Cell Death Discov; 2022 May; 8(1):249. PubMed ID: 35513366
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenic roles of MAFG-AS1 in human cancers.
Ahmadi M; Morshedzadeh F; Ghaderian SMH; Mousavi P; Habibipour L; Peymani M; Abbaszadegan MR; Ghafouri-Fard S
Clin Transl Oncol; 2024 Jan; 26(1):52-68. PubMed ID: 37351806
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
Wang J; Zhong P; Hua H
Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis.
Liang C; Liu J; Ge H; Xu Y; Li G; Wu J
Clin Chim Acta; 2018 Sep; 484():91-98. PubMed ID: 29778540
[TBL] [Abstract][Full Text] [Related]
17. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
Zhang C; Ren X; Liu Z; Tu C
BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
[TBL] [Abstract][Full Text] [Related]
18. MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression.
Li P; Shi Y; Guo M; Xu H; Zhan M; Wang Z; Chen Y
Front Oncol; 2022; 12():856580. PubMed ID: 35992831
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of long non-coding RNA MAFG-AS1 represses tumorigenesis of colorectal cancer cells through the microRNA-149-3p-dependent inhibition of HOXB8.
Ruan Z; Deng H; Liang M; Xu Z; Lai M; Ren H; Deng X; Su X
Cancer Cell Int; 2020; 20():511. PubMed ID: 33093810
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis.
Fu L; Zhang G; Wang Y; Lu T; Liu B; Jiao Y; Ma H; Ma S; Yang K; Cai H
Dis Markers; 2022; 2022():4466776. PubMed ID: 35783010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
